ES541930A0 - Procedimiento de obtener un preparado virico contra la enfermedad de marek. - Google Patents

Procedimiento de obtener un preparado virico contra la enfermedad de marek.

Info

Publication number
ES541930A0
ES541930A0 ES541930A ES541930A ES541930A0 ES 541930 A0 ES541930 A0 ES 541930A0 ES 541930 A ES541930 A ES 541930A ES 541930 A ES541930 A ES 541930A ES 541930 A0 ES541930 A0 ES 541930A0
Authority
ES
Spain
Prior art keywords
disease
marek
virus
mdv
monovalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541930A
Other languages
English (en)
Other versions
ES8605680A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centraal Diergeneeskundig Instituut
Original Assignee
Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneeskundig Instituut filed Critical Centraal Diergeneeskundig Instituut
Publication of ES541930A0 publication Critical patent/ES541930A0/es
Publication of ES8605680A1 publication Critical patent/ES8605680A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/816Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES541930A 1984-04-09 1985-04-03 Procedimiento de obtener un preparado virico contra la enfermedad de marek. Expired ES8605680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (2)

Publication Number Publication Date
ES541930A0 true ES541930A0 (es) 1986-04-16
ES8605680A1 ES8605680A1 (es) 1986-04-16

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541930A Expired ES8605680A1 (es) 1984-04-09 1985-04-03 Procedimiento de obtener un preparado virico contra la enfermedad de marek.

Country Status (17)

Country Link
US (1) US4673572A (es)
EP (1) EP0159743B1 (es)
JP (1) JPS6123A (es)
AT (1) ATE56364T1 (es)
AU (1) AU574164B2 (es)
CA (1) CA1251397A (es)
DD (1) DD232822A5 (es)
DE (1) DE3579617D1 (es)
ES (1) ES8605680A1 (es)
HU (1) HU194496B (es)
IL (1) IL74809A (es)
IN (1) IN163229B (es)
MX (1) MX7718E (es)
NL (1) NL8401120A (es)
WO (1) WO1985004588A1 (es)
YU (1) YU44687B (es)
ZA (1) ZA852564B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
CA2257409A1 (en) * 1996-06-04 1997-12-11 University Of Georgia Research Foundation, Inc. Modified live avian polyomavirus vaccine in psittacine birds
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
EA030866B1 (ru) 2012-03-22 2018-10-31 Мериал, Инк. Модифицированный вирус болезни марека и вакцины на его основе

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
NL8401120A (nl) 1985-11-01
YU59985A (en) 1988-06-30
ZA852564B (en) 1985-11-27
DD232822A5 (de) 1986-02-12
AU574164B2 (en) 1988-06-30
AU4156185A (en) 1985-11-01
EP0159743B1 (en) 1990-09-12
IN163229B (es) 1988-08-27
DE3579617D1 (de) 1990-10-18
WO1985004588A1 (en) 1985-10-24
ES8605680A1 (es) 1986-04-16
JPH0317808B2 (es) 1991-03-11
EP0159743A1 (en) 1985-10-30
CA1251397A (en) 1989-03-21
YU44687B (en) 1990-12-31
IL74809A0 (en) 1985-07-31
HUT38542A (en) 1986-06-30
US4673572A (en) 1987-06-16
JPS6123A (ja) 1986-01-06
ATE56364T1 (de) 1990-09-15
MX7718E (es) 1990-10-10
HU194496B (en) 1988-02-29
IL74809A (en) 1990-09-17

Similar Documents

Publication Publication Date Title
Brown et al. Antigenic differences between isolates of swine vesicular disease virus and their relationship to coxsackie B5 virus
Wiktor et al. Induction and biological properties of defective interfering particles of rabies virus
ES541930A0 (es) Procedimiento de obtener un preparado virico contra la enfermedad de marek.
Powell Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
ALLEN et al. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity
US4895717A (en) Revertant serotype 1 Marek's disease vaccine
CA1292689C (en) Live vaccine for contagious disease of chickens
CA2185407A1 (en) Sustainable chick cell line infected with marek's disease virus
Morita et al. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain
US4895718A (en) Serotype 2 Marek's disease vaccine
CA2222482A1 (en) Non-virulent mycoplasma synoviae and vaccine thereof
NZ272548A (en) Attenuated strain of mareks disease virus (a herpes virus) and its use in poultry vaccines
Wiebe et al. Virion envelope glycoproteins as epidermiological markers of Venezuelan encephalitis virus isolates
Carmichael et al. Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
CA2112225C (en) Attenuated revertant serotype 1 marek's disease vaccine
JPS5756430A (en) Live virus vaccine for canine parainfluenza
US5565202A (en) Low enhancement serotype 2 vaccine for marek's disease
Eisenstein et al. Salmonella vaccines: Protection by endotoxin protein and lipopolysaccharide in two different mouse strains.
JP3040157B2 (ja) イヌパルボウイルス(cpv)を含む弱毒イヌパルボウイルスワクチンとイヌ科動物におけるcpv感染予防
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Allison Tumour Viruses: Are Observations on Tumour Viruses in Animals Applicable to Man?
CA1289881C (en) Vaccine against herpes simplex
KR960016906A (ko) 약독화 수두 생바이러스 백신 및 그의 제조방법